Rankings
▼
Calendar
GERN Q1 2023 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena
GERN
Geron Corporation
$1B
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$21,000
-82.9% YoY
Gross Profit
$21,000
100.0% margin
Operating Income
-$40M
-190914.3% margin
Net Income
-$38M
-181533.3% margin
EPS (Diluted)
$-0.07
QoQ Revenue Growth
-79.6%
Cash Flow
Operating Cash Flow
-$46M
Free Cash Flow
-$47M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$425M
Total Liabilities
$99M
Stockholders' Equity
$326M
Cash & Equivalents
$113M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$21,000
$123,000
-82.9%
Gross Profit
$21,000
-$22M
+100.1%
Operating Income
-$40M
-$29M
-39.8%
Net Income
-$38M
-$30M
-26.7%
← FY 2023
All Quarters
Q2 2023 →